GPCR
Structure Therapeutics Inc.
+0.15 (+0.42%)35.65USD346K成交股數7.6B市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-05下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 100M | 66.5M | 59.0M | 54.7M | 42.9M | 33.5M | 32.6M | 22.1M | 20.7M | 17.5M | 19.4M | 13.1M |
| 銷售管理費用 | 18.6M | 22.9M | 14.8M | 15.7M | 13.4M | 13.6M | 13.2M | 11.3M | 11.3M | 8.6M | 6.6M | 6.5M |
| 營業利益 | −119M+111% | −89.4M+90% | −73.8M+61% | −70.5M+111% | −56.3M+76% | −47.1M+80% | −45.8M+76% | −33.3M+70% | −32.0M | −26.1M | −26.0M | −19.6M |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −106M+127% | −76.0M+108% | −65.7M+93% | −61.7M+137% | −46.8M+80% | −36.5M+53% | −34.0M+46% | −26.0M+45% | −26.0M | −23.9M | −23.3M | −18.0M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.49+81% | -0.35+67% | -0.37+85% | -0.36+100% | -0.27+42% | -0.210% | -0.200% | -0.18-28% | -0.19 | -0.21 | -0.20 | -0.25 |
| 稀釋股數 | 218M | 217M | 175M | 173M | 172M | 158M | 172M | 148M | 140M | 115M | 115M | 71.7M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 273M | 316M | 103M | 147M | 152M | 170M | 172M | 382M | 97.8M | 50.6M | 40.6M | 126M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 1.4B | 1.5B | 832M | 816M | 867M | 903M | 933M | 947M | 457M | 216M | 229M | 247M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 71.0M | 61.0M | 62.1M | 44.4M | 41.9M | 38.5M | 36.4M | 26.0M | 27.4M | 23.4M | 15.0M | 11.0M |
| 股東權益 | 1.4B | 1.4B | 770M | 772M | 825M | 865M | 897M | 921M | 430M | 193M | 214M | 236M |
| 負債比 | 5.0% | 4.0% | 7.5% | 5.4% | 4.8% | 4.3% | 3.9% | 2.7% | 6.0% | 10.8% | 6.5% | 4.4% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 15.2M | – | – | −52.2M+53% | – | – | – | −34.1M | – | – | −20.3M |
| 資本支出 | – | 1.2M | – | – | 314K | – | – | – | 162K | – | – | – |
| 自由現金流 | – | 14.1M | – | – | −52.5M+53% | – | – | – | −34.2M | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −141M | –% | -0.80 | −226M |
| FY2024 | – | – | −123M | –% | -0.78 | −118M |
| FY2023 | – | – | −89.6M | –% | -0.81 | −81.7M |
| FY2022 | – | – | −51.3M | –% | -5.51 | −46.3M |